You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Advancing a Mucosal HSV-2 Vaccine Towards Clinical Trials

    SBC: Biomedical Research Models, Inc.            Topic: NIAID

    DESCRIPTION (provided by applicant): Globally, an estimated 16.2% of the human population is infected with HSV-2 including gt17% of the U.S. adult population. Genital herpes is associated with an increased risk of HIV acquisition and transmission and HSV-2infection can cause neonatal herpes with high infant mortality. HSV-2 infection in the adult population has increased substantially in the past ...

    SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  2. Advancing a Mucosal HSV-2 Vaccine Towards Clinical Trials

    SBC: Biomedical Research Models, Inc.            Topic: R

    DESCRIPTION provided by applicant Globally an estimated of the human population is infected with HSV including andgt of the U S adult population Genital herpes is associated with an increased risk of HIV acquisition and transmission and HSV infection can cause neonatal herpes with high infant mortality HSV infection in the adult population has increased substantially in the ...

    SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  3. A FAP-Activated Proteasome Inhibitor for Killing Solid Tumors

    SBC: ARISAPH PHARMACEUTICALS, INC.            Topic: 102

    DESCRIPTION provided by applicant Cancer is the second leading cause of death after heart disease in the US Chemotherapy is a mainstay of treatment after surgical removal of tumors but the balance of clinical benefit versus disabling or life threatening side effects is often uncertain Genotyping of cancers to identify mutated oncogenes has enabled an era of targeted therapy Drugs targeting ...

    STTR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  4. A High Performance Point-of-Care Device for Umbilical Cord Blood Processing

    SBC: CYTOVERA, INC.            Topic: OD

    DESCRIPTION (provided by applicant): This project aims to continue development and validation of a novel microfluidics device developed during Phase I that preserves the maximal viability, recovery, and function of cord blood hematopoietic stem cells (HSC). Allogeneic HSC transplantation is the elective treatment for over 50 life threatening diseases including leukemia and lymphoma. However due to ...

    SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  5. Amelioration of Claustrophobia and Disruptive Patient Motion in MR Imaging

    SBC: HYPNALGESICS, LLC            Topic: 213

    DESCRIPTION provided by applicant Claustrophobia and disruptive patient motion longtime common impediments to MRI examination can be prevented or ameliorated with a non pharmacologic behavioral intervention administered by trained staff The potential benefits of such an intervention are highly significant as current practice alternatives are to cancel the study or administer sedation Inabilit ...

    SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  6. An Integrated THz System for DNP-enhanced NMR Spectroscopy

    SBC: BRIDGE 12 TECHNOLOGIES, INC.            Topic: 100

    DESCRIPTION provided by applicant The proposed research focuses on the development of a DNP NMR system for Dynamic Nuclear Polarization DNP enhanced solid state NMR spectroscopy at MHz High resolution structures are essential to the understanding of the complex functions of bio macromolecules and NMR spectroscopy is a major source for such information However the method suffers from an ...

    SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  7. An intervention to improve adolescent headache self-management

    SBC: Inflexxion, Inc.            Topic: NICHD

    DESCRIPTION provided by applicant A mobile based intervention to improve adolescentsandapos headache self management Abstract Headache pain is a common and significant problem for adolescents King et al As headaches become more frequent and severe the negative impact on happiness increases and adolescents report less satisfaction with their health and with their life Sillampaa ...

    SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  8. A potassium-ATP channel opener for prevention of contrast-induced nephropathy

    SBC: RADIKAL THERAPEUTICS, INC.            Topic: NIDDK

    Contrast media (CM) induced nephropathy (CIN) remains prevalent and debilitating, the third most common cause of acute renal failure. Based on more than 80 million (M) CM injections in the USA per annum, of which 10% take place in a population highly susceptible to the development of CIN, and a unit pricing of 200 per course, we estimate the total domestic potential market equals 1.6B. At presen ...

    SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  9. Brain penetrant Hsp90 inhibitors for Alzheimer's disease

    SBC: YUMA THERAPEUTICS CORPORAITON            Topic: NIA

    DESCRIPTION provided by applicant Neurodegeneration in Alzheimerandapos s disease AD may result from deposition of A as plaques in brain tissue However less effort has been made to elucidate the role of tau containing neurofibrillary tangles NFTs in AD Accumulating evidence suggests that tau containing NFTs is an important component in the initiation and progression of AD and other neu ...

    STTR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  10. Compact Adaptive Optics Clinical Prototype for Retinal Imaging

    SBC: PHYSICAL SCIENCES INC.            Topic: NEI

    DESCRIPTION (provided by applicant): Physical Sciences Inc. (PSI) is completing a Phase II program demonstrating a compact research instrument that integrates adaptive optics (AO) into a line scanning ophthalmoscope (LSO). The bench-top AO-LSO instrument significantly reduces the size, complexity, and cost of research AO scanning laser ophthalmoscopes (AOSLO), with the goal of transitioning adapti ...

    SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government